Jekiseni giredhi sodium hyaluronate
Product Brief
Sodium hyaluronate chikamu chikuru chekubatanidza nyama senge munhu intercellularsubstance, vitreous body, uye synovial fluid, nezvimwewo, uye ine hunhu hwekuchengeta mvura, kuchengetedza nzvimbo yekunze, kudzora osmotic pressure, lubricating, uye kusimudzira kugadzirisa masero.
Pharmaceutical sodium hyaluronate yakakamurwa kuita zvikamu zviviri zvinoenderana nekushandiswa,giredhi remadonhwe uye jekiseni giredhi.Injection giredhi sodium hyaluronate ine mabasa akanaka ekunyorovesa,kuzora,viscoelasticity, kugadzirisa kukuvara kwekashwa, inhibition yekuzvimba, kunyaradza marwadzo, nezvimwe, uye zvinogona inoshandiswa kune ophthalmic viscosurgical zvishandiso uye intra-articular jekiseni.
Hyaluronic acid jekiseni injectable agents inogona kushandiswa kurapa marwadzo emabvi uye muhudyu uye chero zvimwe zviratidzo zveosteoarthritis.
Mujoini rine utano, chinhu chakakora, chinotsvedza chinonzi synovial fluid chinopa mafuta, zvichiita kuti mapfupa atsemure achirwisana.Zvinonyanya kukosha mukudzivirira kusakara nekubvaruka nekuchengetedza mapfupa zvishomanana uye kuita sechinhu chinovhundutsa.
Muvanhu vane osteoarthritis, chinhu chakakosha mu synovial fluid, inozivikanwa se hyaluronic acid, inoputsika.Kuderedza hyaluronic acid kunogona kutungamirira kumarwadzo emajoini uye kuoma.
| Item | Sodium hyaluronate (giredhi inodonha yeziso) |
| Chitarisiko | Simba jena kana rinenge jena |
| Kuchena | ≥ 95.0% |
| PH | 5.0～8.5 |
| Molecular uremu | (0.2～0.25）10 Dha |
| Nucleic acids | A260mm≤ 0.5 |
| Nitrogen | 3.0~4.0% |
| Chitarisiko mhinduro | A600nm≤ 0.001 |
| Simbi inorema | ≤ 20 ppm |
| Arsenic | ≤ 2 ppm |
| Iron | ≤ 80 ppm |
| Lead | ≤ 3ppm |
| Chloride | ≤ 0.5% |
| Mapuroteni | ≤ 0.1% |
| Kurasikirwa nekuoma | ≤ 10% |
| Residue pa ignition | C15.0~20.0% |
| Huwandu hwehutachiona hwese | <100 cfu/g |
| Mtsaru nembiriso | <100 cfu/g |
| Bacterial endotoxin | <0.05 IU / MG |
chigadzirwa Application
| Product Category | Features | Application |
| Sodium Hyaluronate (Giredhi rejekiseni)
| Viscoelasticity, kudzivirira corneal endothelium | Ophthalmic viscosurgical zvishandiso (OVD) |
| Lubricity, viscoelasticity, kugadziriswa kwecartilage yakakuvadzwa, inhibition yekuzvimba, kunyaradza kurwadziwa. | Intra-articular jekiseni, kurapwa kwechirwere chearthritis | |
| Hyaluronic acid uye zvinobva mairi zvine yakanaka biocompatibility uye biodegradability | Anti-adhesive zvigadzirwa, dermal filler |